{"entity":{"type":"insider","cik":"0001815261","url":"/insider/0001815261","json_url":"/insider/0001815261.json","name":"Athyrium Opportunities 2020 LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2020-06-25","last":"2022-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Athyrium Opportunities 2020 LP","source":"filing","n_filings":5,"first_seen":"2020-06-25","last_seen":"2022-11-14"}],"transactions":[{"id":6319186,"accession":"0000899243-22-035696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035696","line_url":"/filing/0000899243-22-035696#line-1","is_derivative":false,"issuer_cik":"0001394967","issuer_name":"BIORA THERAPEUTICS, INC.","issuer_ticker":"BIOR","issuer_name_source":null,"issuer_url":"/issuer/0001394967","owner_cik":null,"owner_name":"Athyrium Opportunities Associates III GP LLC; Ferrell Jeffrey; Athyrium Opportunities Associates Co-Invest LLC; Athyrium Funds GP Holdings LLC; Athyrium Opportunities 2020 LP; Athyrium Opportunities Associates III LP; Athyrium Opportunities III Acquisition LP; Athyrium Opportunities III Co-Invest 1 LP; Athyrium Opportunities III Acquisition 2 LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12506250.0,"shares_display":"12,506,250","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":42362097.0,"shares_owned_after_display":"42,362,097","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2022-11-14","scope":"insider"},{"id":4760269,"accession":"0000899243-21-023620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-023620","line_url":"/filing/0000899243-21-023620#line-1","is_derivative":false,"issuer_cik":"0001540542","issuer_name":"PROGENITY, INC.","issuer_ticker":"PROG","issuer_name_source":null,"issuer_url":"/issuer/0001540542","owner_cik":null,"owner_name":"Athyrium Opportunities Fund (A) LP; Athyrium Opportunities 2020 LP; Athyrium Opportunities Associates LP; Athyrium Opportunities Associates III LP; Athyrium Opportunities Fund (B) LP; Athyrium Opportunities III Co-Invest 1 LP; Athyrium Opportunities Associates Co-Invest LLC; Athyrium Opportunities III Acquisition 2 LP; Athyrium Opportunities Associates III GP LLC; Athyrium Opportunities Associates GP LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8097166.0,"shares_display":"8,097,166","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":20000000.02,"total_display":"20,000,000.02","shares_owned_after":36396907.0,"shares_owned_after_display":"36,396,907","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-14","scope":"insider"},{"id":4708400,"accession":"0000899243-21-021813","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-021813","line_url":"/filing/0000899243-21-021813#line-2","is_derivative":false,"issuer_cik":"0001540542","issuer_name":"PROGENITY, INC.","issuer_ticker":"PROG","issuer_name_source":null,"issuer_url":"/issuer/0001540542","owner_cik":null,"owner_name":"Athyrium Opportunities Fund (A) LP; Athyrium Opportunities 2020 LP; Athyrium Opportunities Associates Co-Invest LLC; Athyrium Opportunities Associates III LP; Athyrium Opportunities Fund (B) LP; Athyrium Opportunities Associates III GP LLC; Athyrium Opportunities Associates GP LLC; Athyrium Opportunities III Co-Invest 1 LP; Athyrium Opportunities Associates LP; Athyrium Opportunities III Acquisition 2 LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":961807.0,"shares_display":"961,807","price_per_share":2.86,"price_display":"2.86","price_state":"stated","total_value":2750768.02,"total_display":"2,750,768.02","shares_owned_after":28299741.0,"shares_owned_after_display":"28,299,741","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider"},{"id":4708395,"accession":"0000899243-21-021813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-021813","line_url":"/filing/0000899243-21-021813#line-1","is_derivative":false,"issuer_cik":"0001540542","issuer_name":"PROGENITY, INC.","issuer_ticker":"PROG","issuer_name_source":null,"issuer_url":"/issuer/0001540542","owner_cik":null,"owner_name":"Athyrium Opportunities Fund (A) LP; Athyrium Opportunities 2020 LP; Athyrium Opportunities Associates Co-Invest LLC; Athyrium Opportunities Associates III LP; Athyrium Opportunities Fund (B) LP; Athyrium Opportunities Associates III GP LLC; Athyrium Opportunities Associates GP LLC; Athyrium Opportunities III Co-Invest 1 LP; Athyrium Opportunities Associates LP; Athyrium Opportunities III Acquisition 2 LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":306308.0,"shares_display":"306,308","price_per_share":2.86,"price_display":"2.86","price_state":"stated","total_value":876040.88,"total_display":"876,040.88","shares_owned_after":28299741.0,"shares_owned_after_display":"28,299,741","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-03","scope":"insider"},{"id":2462524,"accession":"0000899243-20-033185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-033185","line_url":"/filing/0000899243-20-033185#line-1","is_derivative":false,"issuer_cik":"0001540542","issuer_name":"PROGENITY, INC.","issuer_ticker":"PROG","issuer_name_source":null,"issuer_url":"/issuer/0001540542","owner_cik":null,"owner_name":"Athyrium Opportunities III Co-Invest 1 LP; Athyrium Opportunities Associates GP LLC; Athyrium Opportunities III Acquisition 2 LP; Athyrium Opportunities Associates Co-Invest LLC; Athyrium Opportunities Fund (B) LP; Athyrium Opportunities Associates III LP; Athyrium Opportunities Fund (A) LP; Athyrium Opportunities 2020 LP; Athyrium Opportunities Associates III GP LLC; Athyrium Opportunities Associates LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4128440.0,"shares_display":"4,128,440","price_per_share":3.27,"price_display":"3.27","price_state":"stated","total_value":13499998.8,"total_display":"13,499,998.80","shares_owned_after":26991626.0,"shares_owned_after_display":"26,991,626","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-09","scope":"insider"},{"id":2169190,"accession":"0000899243-20-017651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-017651","line_url":"/filing/0000899243-20-017651#line-3","is_derivative":false,"issuer_cik":"0001540542","issuer_name":"PROGENITY, INC.","issuer_ticker":"PROG","issuer_name_source":null,"issuer_url":"/issuer/0001540542","owner_cik":null,"owner_name":"Athyrium Opportunities III Acquisition 2 LP; Athyrium Opportunities Associates GP LLC; Athyrium Opportunities III Co-Invest 1 LP; Athyrium Opportunities Associates Co-Invest LLC; Athyrium Opportunities Associates III GP LLC; Athyrium Opportunities Fund (A) LP; Athyrium Opportunities 2020 LP; Athyrium Opportunities Associates LP; Athyrium Opportunities Fund (B) LP; Athyrium Opportunities Associates III LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3333333.0,"shares_display":"3,333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":49999995.0,"total_display":"49,999,995.00","shares_owned_after":23303346.0,"shares_owned_after_display":"23,303,346","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001580063","name":"BIORA THERAPEUTICS, INC.","url":"/issuer/0001580063","role":"Ten percent owner","n_filings":5,"first_seen":"2020-06-25","last_seen":"2022-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001815261","retrieved_at":"2026-08-21T23:10:39+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}